Cognito Therapeutics Group
Cognito Therapeutics Group is a startup headquartered in Cambridge, United States, founded in 2025. It has raised at least $196.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Cognito Therapeutics Group has raised at least $196.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Cognito Therapeutics Group sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- 2Pi
- Acceleron Fusion
- actnano
- AIScientists
- Apeiron Labs
- Aptamino
- Arches Medical Independents
- Aviceda Therapeutics
- Axoft
- Blitzy
- Caldera Therapeutics
Related
- Innovation profile of Cambridge
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Cognito Therapeutics Group do?
Cognito Therapeutics Group is classed in healthcare in its filings with the US Securities and Exchange Commission.
How much has Cognito Therapeutics Group raised?
At least $196.3m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Cognito Therapeutics Group based?
Cognito Therapeutics Group is headquartered in Cambridge, United States.
When was Cognito Therapeutics Group founded?
Cognito Therapeutics Group was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.